Longitudinal Changes in Ganglion Cell Complex Thickness Before and After Intravitreal Bevacizumab Injections in Diabetic Macular Edema
Background/Objectives: Diabetic macular edema (DME) is a major cause of vision impairment in patients with diabetes mellitus, and intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy is widely used for its management. However, the longitudinal effects of anti-VEGF treatment on the ganglion cell comp...